| Mel Johnson, | |
|
700 30th Ave S, Moorhead, MN 56560-4926 | |
| (218) 331-2668 | |
| Not Available |
| Full Name | Mel Johnson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 700 30th Ave S, Moorhead, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265169965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 125619 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mel Johnson, 7671 Cub Creek Way, Horace, ND 58047-5527 Ph: (218) 234-4108 | Mel Johnson, 700 30th Ave S, Moorhead, MN 56560-4926 Ph: (218) 331-2668 |
News Archive
Critical Outcome Technologies Inc. announced today that the Company was selected by the Consulate General of Canada and BIOTECanada to attend a life sciences partnering mission in Boston, MA. This initiative is being held in conjunction with the BioPharm America conference taking place September 15-17, 2010.
Children under the age of 4 years benefit from instrument-based vision screening rather than visual acuity tests since the former is quick, requires minimal cooperation of the child, and is not dependent on their behavioral responses, says a policy statement released by the American Academy of Pediatrics.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired TREK Diagnostic Systems, a global provider of microbiology solutions, including blood culture, microorganism identification and antibiotic susceptibility testing (AST) products, from Magellan Biosciences. Based near Cleveland, Ohio, the company had full year revenue in 2010 of $34 million and has 150 employees.
An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Researchers at the Catalan Institute of Oncology-Bellvitge Biomedical Research Institute, led by David Garcia-Mollev- have identified 5 genes differentially expressed in normal accompanying cells in colorectal tumors.
› Verified 8 days ago
Mr. Rollin Elis Wiger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Highway 10 E, Moorhead, MN 56560 Phone: 218-236-5268 Fax: 218-233-6799 | |
Dr. Kristie Marie Lockhart, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3301 Highway 10 E, T-0658, Moorhead, MN 56560 Phone: 218-233-2953 Fax: 218-233-2953 | |
Wendy A Gress, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Main Ave, Moorhead, MN 56560 Phone: 218-236-0252 Fax: 218-236-0892 | |
Andrea Kaye Plath, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Highway 10 E, Moorhead, MN 56560 Phone: 218-236-0345 | |
Ms. Kimberly Ann Sweeney, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Highway 10 E, Moorhead, MN 56560 Phone: 218-236-0345 Fax: 218-236-0354 | |
Corey Wayne Burnside, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Hwy 10 E, Cashwise Pharmacy #15, Moorhead, MN 56560 Phone: 218-236-0345 Fax: 218-236-0354 | |
Erianne Siena Gibson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 40th Ave S, Moorhead, MN 56560 Phone: 218-359-4007 Fax: 218-359-4010 |